HLA-C*08 structures

8 items

Page 1 of 1 | 25 items per page | ordered by release date, descending

1

6ULK	HLA-C*08:02 binding "GADGVGKSAL" at 1.90Å resolution MOLECULAR BASIS FOR TUMOR INFILTRATING TCR RECOGNITION OF HOTSPOT KRAS-G12D MUTATION Human Deposited 2019 Decamer peptide (10aa) Class I alpha Beta 2 microglobulin
6ULR	HLA-C*08:02 presenting "GADGVGKSA" to Alpha/Beta T cell receptor at 3.20Å resolution MOLECULAR BASIS FOR TUMOR INFILTRATING TCR RECOGNITION OF HOTSPOT KRAS-G12D MUTATION Human Deposited 2019 Nonamer peptide (9aa) Class I alpha Beta 2 microglobulin T cell receptor alpha T cell receptor beta
6ULN	HLA-C*08:02 presenting "GADGVGKSA" to Alpha/Beta T cell receptor at 2.01Å resolution MOLECULAR BASIS FOR TUMOR INFILTRATING TCR RECOGNITION OF HOTSPOT KRAS-G12D MUTATION Human Deposited 2019 Nonamer peptide (9aa) Class I alpha Beta 2 microglobulin T cell receptor alpha T cell receptor beta
6UON	HLA-C*08:02 presenting "GADGVGKSAL" to Alpha/Beta T cell receptor at 3.50Å resolution MOLECULAR BASIS FOR TUMOR INFILTRATING TCR RECOGNITION OF HOTSPOT KRAS-G12D MUTATION Human Deposited 2019 Decamer peptide (10aa) Class I alpha Beta 2 microglobulin T cell receptor alpha T cell receptor beta
6ULI	HLA-C*08:02 binding "GADGVGKSA" at 1.88Å resolution MOLECULAR BASIS FOR TUMOR INFILTRATING TCR RECOGNITION OF HOTSPOT KRAS-G12D MUTATION Human Deposited 2019 Nonamer peptide (9aa) Class I alpha Beta 2 microglobulin
6JTN	HLA-C*08:02 binding "GADGVGKSAL" at 1.90Å resolution CRYSTAL STRUCTURE OF HLA-C08 IN COMPLEX WITH A TUMOR MUT10M PEPTIDE Human Deposited 2019 Decamer peptide (10aa) Class I alpha Beta 2 microglobulin
6JTP	HLA-C*08:02 binding "GADGVGKSA" at 1.90Å resolution CRYSTAL STRUCTURE OF HLA-C08 IN COMPLEX WITH A TUMOR MUT9M PEPTIDE Human Deposited 2019 Nonamer peptide (9aa) Class I alpha Beta 2 microglobulin
4NT6	HLA-C08:01 binding "GILGFVFTL" at 1.84Å resolution HLA-C0801 CRYSTAL STRUCTURE Human Deposited 2013 Nonamer peptide (9aa) Class I alpha Beta 2 microglobulin

1

Creative Commons Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.